Managers

Uber’s top holders, SoftBank’s Vision Fund and Benchmark, hold 27.3 pct of its stock

Blume locks in $3.3 mln

Blume, a feminine hygiene company, has secured $3.3 million in funding. Grace Chou and Victoria Treyger, partners at Felicis Ventures, led the round with participation from other investors that included Victress Capital.

Firebrand Ventures targets $40 mln for sophomore fund

Firebrand Ventures is seeking to raise $40 million for its second fund, according to an SEC filing. The firm invests makes seed investments in software startups in the greater Midwest.

Public health startup CityBlock grans $65 mln Series B

CityBlock, a public health startup, has raised $65 million in Series B funding, according to a Medium blog post. Redpoint Ventures led the round. In addition to the funding, Elliot Geidt of Redpoint will join CityBlock's board of directors.

Medical device firm Ajax Health rakes in more than $85 mln

Ajax Health, a medical device firm, has raised more than $85 million in funding. HealthQuest Capital led the round with participation from Aisling Capital and Polaris Partners.

VC-backed Alacura appoints CEO

Alacura Medical Transportation Management, a transportation benefit management provider for healthcare insurance plans, has appointed Ken Van Cara as CEO. Previously, he was president and COO at Clarus Healthcare. Alacura's backers include Blue Cross Blue Shield Venture Fund and HCSC Ventures, the venture capital subsidiary of Health Care Service Corporation.

Fund Performance: New Mexico, 2005 to 2012 venture portfolio

Fauna Bio inks $4.1 mln seed

Fauna Bio, a biotechnology company, has raised $4.1 million in seed funding. True Ventures led the round with participation from Longevity Fund, Pacific 8 Ventures, Boom Capital and Beagle Ventures.

PJC to raise $150 mln fifth venture-capital fund

PJC, formerly Point Judith Capital, has set out to raise a $150 million fifth venture-capital fund, according to a filing with the SEC.

HistoSonics picks up $54 mln Series C

Ann Arbor, Michigan-based HistoSonics, a developer of a non-invasive robotics platform and novel beam therapy, has raised $54 million in Series C financing. Varian Medical Systems Inc led the round with participation from other investors that included Johnson & Johnson Innovation - JJDC, Inc, Lumira Ventures, Venture Investors and the State of Wisconsin Investment Board.